CrossrefInfokarte
Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study
Breast Cancer · 2026-11-06
DOI: 10.1007/s12282-026-01936-2 ↗Abstract
Kein Abstract verfügbar.
EUVIMED